Press release
Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics.
Tabulated profiles of prominent psychedelic therapeutics developers. shortlisted on the basis of the number of pipeline products).
Detailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).
An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.
A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.
A detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May).
An analysis of the partnerships that have been established in the recent past (2017-2020 till May),
A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Target Disease Indication
Anxiety and Depression
Trauma
Pain Disorder
Sleep related Disorder
Origin of Psychedelic Substance
Natural
Synthetic
Type of Psychedelic Substance
Gamma-hydroxybutyrate
Ketamine
MDMA
Psilocybin
Route of Administration
Oral
Intranasal
Sublingual
Key Geographies
North America
Europe
Asia-Pacific
Transcripts of interviews held with the following senior level representatives of stakeholder companies
Andrew Chadeayne (Founder & Chief Executive Officer, CaaMTech)
Janakan Krishnarajah (Chief Operating Officer and Chief Medical Officer, iX Biopharma)
Alexander Speiser (Chief Operating Officer, Orthogonal Thinker)
Tracy Cheung, (Chief Communications Officer, COMPASS Pathways)
Key companies covered in the report
Celon Pharma
iX Biopharma
MAPS Public Benefit
MindMed
Janssen Pharmaceuticals
Jazz Pharmaceutical
For additional details, please visit
https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Endocannabinoid System Targeted Therapeutics Market, 2020-2030
2. Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019
3. Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights
4. Neoantigen Targeted Therapies Market, 2019-2030
5. Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis here
News-ID: 2217325 • Views: …
More Releases from Roots Analysis
The Agricultural Biologicals Market Size Worth over USD 40 Billion in 2035 | Roo …
Global Agricultural Biologicals Market Overview
The agricultural biologicals market is a rapidly growing and dynamic industry that is poised to grow at a CAGR of 9.98% in the forecast period 2023-2035. The growth in the agricultural biologicals market size over the next decade is likely to be the result of a rise in the demand for organic food coupled with the growing focus on sustainable agriculture. Agricultural biologics include a vast…
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035 …
Owing to the advanced features and cost-saving potential of automation, stakeholders in the healthcare industry are adopting lab automation systems in order to get precise results and reduce deviations occurring due to manual handling
Roots Analysis has announced the addition of "Lab Automation Market, 2023-2035" report to its list of offerings.
The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology…
The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development
London
Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings.
Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type…
The companion diagnostics development services market, is anticipated to grow at …
Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings.
The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of…
More Releases for Psychedelic
uniMIND Symposium: Exchange on psychedelic research
For the second time, the international academic network uniMIND is organizing a conference focusing on current research around psychedelic topics. The symposium will take place in Maastricht on April 9, 2022. This year's cooperation partner is Maastricht University, one of the most renowned centers of psychedelic research worldwide.
The interest among students in the psychedelic research field continues to grow across disciplines such as psychology, medicine, neuroscience, philosophy, as well as…
Psychedelic Drugs Market: global outlook and overview 2021-2031
Psychedelic Drugs Market: Evolution Contours
Interest in psychedelic medicine has reemerged in psychiatry after a brief period of prohibition of the use of psychedelic substances-from 1950s to the early 1970. Unrefutably, psychedelics or serotonergic hallucinogens show promising potential to treat mood disorders and alcohol dependence. Especially lysergic acid diethylamide (LSD) drug has shown significant safety and tolerability in end-of-life psychological distress.
Read Report Overview: https://www.transparencymarketresearch.com/psychedelic-drugs-market.html
The prohibitive legislatures and discontinuation of research…
Psychedelic Drugs Market 2021: Future Prospects With Covid-19 Impact Analysis 20 …
Psychedelic Drugs report helps clients to be acquainted with new opportunities in the Psychedelic Drugs industry and most important customers for the business growth and increased revenue. This market research report also evaluates the market status, market share, current trends, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. An expert team of innovative analysts, enthusiastic forecasters, knowledgeable researchers and experienced industry experts take…
Psychedelic Drugs Market 2021: Future Prospects With Covid-19 Impact Analysis 20 …
Global Psychedelic Drugs market research report is formulated with the exact understanding of customer requirements. Market status at the global and regional level about Psychedelic Drugs industry is offered through this report which helps to gain business insights at the extensive marketplace. In the universal Psychedelic Drugs business report, complex market insights are turned into simpler version with the help of proven tools and techniques and then provided to the…
Psychedelic Drugs Market Share, Growth by Business Developments 2021 to 2028
Psychedelic Drugs market report emphasizes key market dynamics of Psychedelic Drugs industry and covers historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. This market analysis report proves to be a precious source of information with which businesses can achieve a telescopic view of the current market trends, consumer’s demands and preferences, market situations, opportunities and market status. To build an…
U.S. Psychedelic Drugs Market Comprehensive Analysis, Growth Forecast from 2021 …
Client’s requirements are understood well by experts leveraging their expertise and strong knowledge base to identify and evaluate competition and chalk out strategic programs with short-term goals and long-term objectives. It is helpful in knowing the general conditions prevailing in the market, the marketing and pricing strategy of competitors. The report ascertains the reputation of the firm and its products. The market report also contains the drivers and restraints for…
